172 related articles for article (PubMed ID: 38565645)
1. Pre-enrichment-free detection of hepatocellular carcinoma-specific ctDNA via PDMS and MEMS-based microfluidic sensor.
Çağlayan Arslan Z; Okan M; Külah H
Mikrochim Acta; 2024 Apr; 191(5):229. PubMed ID: 38565645
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
3. Additive manufacturing of three-dimensional (3D) microfluidic-based microelectromechanical systems (MEMS) for acoustofluidic applications.
Cesewski E; Haring AP; Tong Y; Singh M; Thakur R; Laheri S; Read KA; Powell MD; Oestreich KJ; Johnson BN
Lab Chip; 2018 Jul; 18(14):2087-2098. PubMed ID: 29897358
[TBL] [Abstract][Full Text] [Related]
4. Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.
Tao K; Bian Z; Zhang Q; Guo X; Yin C; Wang Y; Zhou K; Wan S; Shi M; Bao D; Yang C; Xing J
EBioMedicine; 2020 Jun; 56():102811. PubMed ID: 32512514
[TBL] [Abstract][Full Text] [Related]
5. Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma.
Oversoe SK; Clement MS; Weber B; Grønbæk H; Hamilton-Dutoit SJ; Sorensen BS; Kelsen J
BMC Cancer; 2021 Apr; 21(1):376. PubMed ID: 33827453
[TBL] [Abstract][Full Text] [Related]
6. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
Howell J; Atkinson SR; Pinato DJ; Knapp S; Ward C; Minisini R; Burlone ME; Leutner M; Pirisi M; Büttner R; Khan SA; Thursz M; Odenthal M; Sharma R
Eur J Cancer; 2019 Jul; 116():56-66. PubMed ID: 31173963
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma.
Lyu X; Tsui YM; Ho DW; Ng IO
Cell Mol Gastroenterol Hepatol; 2022; 13(6):1611-1624. PubMed ID: 35183803
[TBL] [Abstract][Full Text] [Related]
8. Membrane integration into PDMS-free microfluidic platforms for organ-on-chip and analytical chemistry applications.
Schneider S; Gruner D; Richter A; Loskill P
Lab Chip; 2021 May; 21(10):1866-1885. PubMed ID: 33949565
[TBL] [Abstract][Full Text] [Related]
9. Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma.
Nguyen VC; Nguyen TH; Phan TH; Tran TT; Pham TTT; Ho TD; Nguyen HHT; Duong ML; Nguyen CM; Nguyen QB; Bach HT; Kim VV; Pham TA; Nguyen BT; Nguyen TNV; Huynh LAK; Tran VU; Tran TTT; Nguyen TD; Phu DTB; Phan BHH; Nguyen QT; Truong DK; Do TT; Nguyen HN; Phan MD; Giang H; Tran LS
BMC Cancer; 2023 Mar; 23(1):233. PubMed ID: 36915069
[TBL] [Abstract][Full Text] [Related]
10. A pump-free and high-throughput microfluidic chip for highly sensitive SERS assay of gastric cancer-related circulating tumor DNA via a cascade signal amplification strategy.
Cao X; Ge S; Hua W; Zhou X; Lu W; Gu Y; Li Z; Qian Y
J Nanobiotechnology; 2022 Jun; 20(1):271. PubMed ID: 35690820
[TBL] [Abstract][Full Text] [Related]
11. Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity.
Huang A; Zhang X; Zhou SL; Cao Y; Huang XW; Fan J; Yang XR; Zhou J
J Cancer; 2016; 7(13):1907-1914. PubMed ID: 27698932
[TBL] [Abstract][Full Text] [Related]
12. Conventional and emerging strategies for the fabrication and functionalization of PDMS-based microfluidic devices.
Shakeri A; Khan S; Didar TF
Lab Chip; 2021 Aug; 21(16):3053-3075. PubMed ID: 34286800
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic electrochemical aptameric assay integrated on-chip: a potentially convenient sensing platform for the amplified and multiplex analysis of small molecules.
Du Y; Chen C; Zhou M; Dong S; Wang E
Anal Chem; 2011 Mar; 83(5):1523-9. PubMed ID: 21291178
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment.
Sogbe M; Bilbao I; Marchese FP; Zazpe J; De Vito A; Pozuelo M; D'Avola D; Iñarrairaegui M; Berasain C; Arechederra M; Argemi J; Sangro B
Clin Mol Hepatol; 2024 Apr; 30(2):177-190. PubMed ID: 38163441
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic Signature of 3D Hierarchical Porous Chip Enriched Exosomes for Early Detection and Progression Monitoring of Hepatocellular Carcinoma.
Yi K; Wang Y; Rong Y; Bao Y; Liang Y; Chen Y; Liu F; Zhang S; He Y; Liu W; Zhu C; Wu L; Peng J; Chen H; Huang W; Yuan Y; Xie M; Wang F
Adv Sci (Weinh); 2024 Apr; 11(14):e2305204. PubMed ID: 38327127
[TBL] [Abstract][Full Text] [Related]
16. Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study.
Pommergaard HC; Yde CW; Ahlborn LB; Andersen CL; Henriksen TV; Hasselby JP; Rostved AA; Sørensen CL; Rohrberg KS; Nielsen FC; Rasmussen A
Mol Biol Rep; 2022 Feb; 49(2):1609-1616. PubMed ID: 34811635
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing.
Liao W; Yang H; Xu H; Wang Y; Ge P; Ren J; Xu W; Lu X; Sang X; Zhong S; Zhang H; Mao Y
Oncotarget; 2016 Jun; 7(26):40481-40490. PubMed ID: 27248174
[TBL] [Abstract][Full Text] [Related]
18. Rapid and inexpensive method for the simple fabrication of PDMS-based electrochemical sensors for detection in microfluidic devices.
da Silva ENT; Ferreira VS; Lucca BG
Electrophoresis; 2019 May; 40(9):1322-1330. PubMed ID: 30657598
[TBL] [Abstract][Full Text] [Related]
19. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review.
Kopystecka A; Patryn R; Leśniewska M; Budzyńska J; Kozioł I
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298294
[TBL] [Abstract][Full Text] [Related]
20. Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.
Weng J; Atyah M; Zhou C; Ren N
Clin Exp Med; 2020 Aug; 20(3):329-337. PubMed ID: 32239299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
